Real-world outcomes of teriflunomide in relapsing–remitting multiple sclerosis: a prospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Neurology"
DOI: 10.1007/s00415-022-11118-7
Abstract: To explore efficacy, risk factors, safety, and persistence of teriflunomide in relapsing–remitting multiple sclerosis (RRMS) cohort. This prospective, observational cohort study included 217 consecutive teriflunomide treated RRMS patients, 192 of which with at least 3-month… read more here.
Keywords: treatment; remitting multiple; multiple sclerosis; teriflunomide relapsing ... See more keywords